Published in Gene Therapy Weekly, August 26th, 1996
In an effort to bring gene therapy for head and neck cancer one step closer to clinical reality, Ohio researchers Keith M. Wilson et al. conducted a study to determine whether the bystander effect demonstrated in vitro for ganciclovir (GCV)-mediated killing of a HSV-tk gene-infected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.